Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Vernakalant> ?p ?o. }
Showing items 1 to 77 of
77
with 100 items per page.
- Vernakalant abstract "Vernakalant (INN; codenamed RSD1235, proposed tradenames Kynapid and Brinavess) is an investigational drug under regulatory review for the acute conversion of atrial fibrillation. It was initially developed by Cardiome Pharma, and the intravenous formulation was bought for further development by Merck in April 2009. In September 2012, Merck terminated its agreements with Cardiome and has consequently returned all rights of the drug back to Cardiome.On 11 December 2007, the Cardiovascular and Renal Drugs Advisory Committee of the US Food and Drug Administration (FDA) voted to recommend the approval of vernakalant, but in August 2008 the FDA judged that additional information was necessary for approval. The drug (under brand name Brinavess) was approved in Europe on 1 September 2010.An oral formulation underwent Phase II clinical trials between 2005 and 2008.".
- Vernakalant atcPrefix "C01".
- Vernakalant atcSuffix "BG11".
- Vernakalant casNumber "794466-70-9".
- Vernakalant casSupplemental "(HCl)".
- Vernakalant fdaUniiCode "9G468C8B13".
- Vernakalant iupacName "(3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)".
- Vernakalant iupacName "ethoxy]cyclohexyl}pyrrolidin-3-ol".
- Vernakalant pubchem "9930049".
- Vernakalant thumbnail Vernakalant.svg?width=300.
- Vernakalant wikiPageID "16313649".
- Vernakalant wikiPageRevisionID "602464161".
- Vernakalant atcPrefix "1.0".
- Vernakalant atcSuffix "BG11".
- Vernakalant c "20".
- Vernakalant casNumber "794466".
- Vernakalant chemspiderid "8105680".
- Vernakalant h "31".
- Vernakalant hasPhotoCollection Vernakalant.
- Vernakalant inchi "1".
- Vernakalant inchikey "VBHQKCBVWWUUKN-KZNAEPCWBT".
- Vernakalant iupacName "-1".
- Vernakalant iupacName "ethoxy]cyclohexyl}pyrrolidin-3-ol".
- Vernakalant legalStatus "Rx-only".
- Vernakalant licenceEu "Brinavess".
- Vernakalant molecularWeight "349.464".
- Vernakalant n "1".
- Vernakalant o "4".
- Vernakalant pubchem "9930049".
- Vernakalant routesOfAdministration "Intravenous, oral".
- Vernakalant smiles "OC".
- Vernakalant stdinchi "1".
- Vernakalant stdinchikey "VBHQKCBVWWUUKN-KZNAEPCWSA-N".
- Vernakalant unii "9".
- Vernakalant verifiedfields "changed".
- Vernakalant verifiedrevid "446573380".
- Vernakalant watchedfields "changed".
- Vernakalant subject Category:Alcohols.
- Vernakalant subject Category:Antiarrhythmic_agents.
- Vernakalant subject Category:Phenol_ethers.
- Vernakalant subject Category:Pyrrolidines.
- Vernakalant type Abstraction100002137.
- Vernakalant type Agent114778436.
- Vernakalant type Alcohol107884567.
- Vernakalant type Alcohols.
- Vernakalant type Beverage107881800.
- Vernakalant type CausalAgent100007347.
- Vernakalant type Drug103247620.
- Vernakalant type DrugOfAbuse103248958.
- Vernakalant type Element114840755.
- Vernakalant type Fluid114939900.
- Vernakalant type Food100021265.
- Vernakalant type Liquid114940386.
- Vernakalant type Matter100020827.
- Vernakalant type Part113809207.
- Vernakalant type PhenolEthers.
- Vernakalant type PhysicalEntity100001930.
- Vernakalant type Quintessence114847103.
- Vernakalant type Relation100031921.
- Vernakalant type Substance100019613.
- Vernakalant type Substance100020090.
- Vernakalant type Drug.
- Vernakalant type DrugProduct.
- Vernakalant type FunctionalSubstance.
- Vernakalant comment "Vernakalant (INN; codenamed RSD1235, proposed tradenames Kynapid and Brinavess) is an investigational drug under regulatory review for the acute conversion of atrial fibrillation. It was initially developed by Cardiome Pharma, and the intravenous formulation was bought for further development by Merck in April 2009.".
- Vernakalant label "Vernakalant".
- Vernakalant label "Vernakalant".
- Vernakalant label "Vernakalant".
- Vernakalant sameAs Vernakalant.
- Vernakalant sameAs Vernakalant.
- Vernakalant sameAs m.03wgqxr.
- Vernakalant sameAs Q665725.
- Vernakalant sameAs Q665725.
- Vernakalant sameAs Vernakalant.
- Vernakalant wasDerivedFrom Vernakalant?oldid=602464161.
- Vernakalant depiction Vernakalant.svg.
- Vernakalant isPrimaryTopicOf Vernakalant.